Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2003

View Archived Issues

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Isis Pharmaceuticals

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Proneuron

Improved motor response found with CP-101606 in hemiparkinsonian rats

HP-184 improves hindlimb movement and myelination in rats with spinal cord injury

Subjective improvement in spasticity associated with cannabinoids in multiple sclerosis

Kalypsys and CV Therapeutics collaborate on cardiovascular disease

Boehringer Ingelheim exercises therapeutic antibody option

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Ortec

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Oncolytics Biotech

Prevacid NapraPAC receives FDA approval

Good tolerability profile for OSI-461 in advanced cancer patients

FTY-720 exerts selective antitumor effects on hepatoma cell lines

New immunosuppressants and their therapeutic use reported by Sankyo

Novel TLR modulators with utility in sepsis developed at Mochida

New prostanoid EP4 antagonists under study at Pfizer

Merck presents new GABA(A) ligands for anxiety, convulsions, etc.

New phthalocyanine-based photosensitizers designed by Nihon U. scientists

AstraZeneca presents three related series of alpha7 nAChR agonists

New antifungal azoles prepared and tested at Ranbaxy

Chugai claims new antiestrogens that inhibit osteoclast differentiation

Novel HDAC inhibitors identified at AstraZeneca

Allergan completes Oculex acquisition

BioMS submits Canadian pre-CTA package for MBP-8298

Celltech completes integration of OGS

Phase I/II study evaluates Advexin oral rinse for oral premalignancies

Encouraging preliminary results from rat carcinogenicity study of Preos

Promising preliminary phase I data for HER-2 Protein AutoVac vaccine

SkyePharma seeks U.K. approval of DepoMorphine

Canadian CTA filed for Tectin in refractory severe chronic pain

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...